Regeneron Pharmaceuticals
REGN
#231
Rank
โ‚น9.259 T
Marketcap
โ‚น89,512
Share price
0.56%
Change (1 day)
43.39%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น535.51 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น16.89 Billion. In 2025 the company made an earning of โ‚น488.86 Billion, an increase over its 2024 earnings that were of โ‚น446.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น535.51 B9.54%
2025 โ‚น488.86 B9.43%
2024 โ‚น446.72 B13.83%
2023 โ‚น392.46 B-13.57%
2022 โ‚น454.10 B-47.9%
2021 โ‚น871.58 B144.75%
2020 โ‚น356.11 B56.86%
2019 โ‚น227.02 B-4.87%
2018 โ‚น238.65 B22.86%
2017 โ‚น194.25 B56.3%
2016 โ‚น124.28 B8.55%
2015 โ‚น114.49 B54.53%
2014 โ‚น74.09 B11.14%
2013 โ‚น66.67 B72.13%
2012 โ‚น38.73 B-285.93%
2011 -โ‚น20.84 Billion121.73%
2010 -โ‚น9.4 Billion37.18%
2009 -โ‚น6.85 Billion-14.6%
2008 -โ‚น8.02 Billion-25.02%
2007 -โ‚น10.7 Billion6.32%
2006 -โ‚น10.07 Billion-186.52%
2005 โ‚น11.62 B2103.7%
2004 โ‚น0.52 B-105.66%
2003 -โ‚น9.33 Billion-18.18%
2002 -โ‚น11.4 Billion42.33%
2001 -โ‚น8.01 Billion129.35%
2000 -โ‚น3.5 Billion51.87%
1999 -โ‚น2.3 Billion92.19%
1998 -โ‚น1.2 Billion66.23%
1997 -โ‚น0.72 Billion-55.49%
1996 -โ‚น1.62 Billion103.53%
1995 -โ‚น0.8 Billion-70.89%
1994 -โ‚น2.73 Billion-26.08%
1993 -โ‚น3.7 Billion114.67%
1992 -โ‚น1.72 Billion196.77%
1991 -โ‚น0.58 Billion87.88%
1990 -โ‚น0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.749 T 229.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.181 T 122.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น1.032 T 94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น727.86 B 36.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น41.59 B-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น114.15 B-78.52%๐Ÿ‡บ๐Ÿ‡ธ USA